Cancer BiologybioRxivPreprint
Profound CD4+ T-Cell Reprogramming by Melphalan-Driven Oxidative Stress in High-Risk Multiple Myeloma
Mara John, Nazia Afrin, Xiang Zhou…·Angela Riedel
This study shows that melphalan treatment causes oxidative stress in T cells, reducing CD4+ naive T cells in high-risk multiple myeloma patients.
DOI 10.64898/2026.06.08.730835